New data show Paxlovid outperforms molnupiravir against severe COVID-19 outcomes

… COVID-19 in adults than is molnupiravir, another antiviral drug. The study was conducted in Hong Kong in 2022. Researchers said they also found no …

Read more at www.cidrap.umn.edu